Stocks · News reference
UBS Maintains Buy on Solventum, Raises Price Target to $101
UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105
Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101
Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.